Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Aug 31:9:500.
doi: 10.3389/fendo.2018.00500. eCollection 2018.

The Implications of Vitamin D Status During Pregnancy on Mother and her Developing Child

Affiliations
Review

The Implications of Vitamin D Status During Pregnancy on Mother and her Developing Child

Carol L Wagner et al. Front Endocrinol (Lausanne). .

Abstract

Pregnancy is a time of tremendous growth and physiological changes for mother and her developing fetus with lifelong implications for the child. The concert of actions that must occur so mother does not reject the foreign tissue of the fetus is substantial. There must be exquisite balance between maternal tolerance to these foreign proteins of paternal origin but also immune surveillance and function such that the mother is not immunocompromised. When this process goes awry, the mother may experience such pregnancy complications as preeclampsia and infections. Vitamin D deficiency affects these processes. Controversy continues with regard to the optimal daily intake of vitamin D, when sunlight exposure should be taken into account, and how to define sufficiency during such vulnerable and critical periods of development. The importance of vitamin D supplementation during pregnancy in preventing some of the health risks to the mother and fetus appears linked to achieving 25(OH)D concentrations >40 ng/mL, the beginning point of the plateau where conversion of the vitamin D metabolite 25(OH)D, the pre-hormone, to 1,25(OH)2D, the active hormone, is optimized. Throughout pregnancy, the delivery of adequate vitamin D substrate-through sunlight or supplement-is required to protect both mother and fetus, and when in sufficient supply, favorably impacts the epigenome of the fetus, and in turn, long term health. There is a growing need for future research endeavors to focus not only on critical period(s) from pre-conception through pregnancy, but throughout life to prevent certain epigenetic changes that adversely affect health. There is urgency based on emerging research to correct deficiency and maintain optimal vitamin D status. The impact of vitamin D and its metabolites on genetic signaling during pregnancy in both mother and fetus is an area of great activity and still in its early stages. While vitamin D repletion during pregnancy minimizes the risk of certain adverse outcomes (e.g., preterm birth, asthma, preeclampsia, and gestational diabetes), the mechanisms of how these processes occur are not fully understood. As we intensify our research efforts in these areas. it is only a matter of time that such mechanisms will be defined.

Keywords: cholecalciferol; developmental origins of later disease; fetal development; genetic effects; health effects; immune mediator; pregnancy; vitamin D.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Barker DJ, Osmond C. Diet and coronary heart disease in England and Wales during and after the second world war. J Epidemiol Community Health (1986) 40:37–44. 10.1136/jech.40.1.37 - DOI - PMC - PubMed
    1. Daly S, Mills JL, Molloy AM, Conley M, Lee YJ, Kirke PN, et al. . Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet (1997) 350:1666–9. 10.1016/S0140-6736(97)07247-4 - DOI - PubMed
    1. Hibbard ED, Smithells RW. Preliminary communications. folic acid metabolism and human embryopathy. Lancet (1965) 285:1254 10.1016/S0140-6736(65)91895-7 - DOI
    1. Smithells R, Sheppard S, Schorah C. Vitamin deficiencies and neural tube defects. Arch Dis Child. (1976) 51:944–50. 10.1136/adc.51.12.944 - DOI - PMC - PubMed
    1. Haddad JG, Chyu K. Competitive protein-binding radioassay for 25-hydroxycholecalciferol. J Clin Endocrinal Metab. (1971) 33:992–5. 10.1210/jcem-33-6-992 - DOI - PubMed